Pathogenicity and virulence of Clostridium botulinum

References

• Hauschild AHW. Clostridium botulinum. In: Doyle M, editor. Foodborne bacterial pathogens. New York: Marcel Dekker Inc; 1989. pp. 111–28.
   Google Scholar
• Hatheway CL. Botulism. In: Barlows A, WJ Hausler Jr., M Ohashi, A Turano, Lennete EH, editors. Laboratory diagnosis of infectious diseases. New York: Springer; 1988. p. 111–133.
   Google Scholar
• Sobel J. Botulism. Clin Infect Dis. 2005;41(8):1167–1173.
   PubMed Web of Science ®Google Scholar
• Johnson EA. Clostridium botulinum. In: Doyle M, Buchanan R, editors. Food Microbiology. Washington DC: ASM Press; 2019. pp. 487–512.
   Google Scholar
• Johnson EA. Clostridium botulinum and the Most Poisonous Poison. In: Gurtler J, Doyle M, Kornacki J, editors. Foodborne Pathogens. Cam, Switzerland: Springer; 2017. pp.553–601.
   Google Scholar
• Rossetto O, Pirazzini M, Fabris F, et al. Botulinum Neurotoxins: Mechanism of Action . Handbook of Experimental Pharmacology. 2021;263 :35–47.
   PubMedGoogle Scholar
• Hauschild AHW. Clostridium botulinum. In: editors, Hauschild A, and K Dodds. Ecology and Control in Foods. 1st ed. Boca Raton: CRC Press; 1993.
   Google Scholar
• Minton NP, Clarke DJ. Clostridia. New York: Plenum; 1989.
   Google Scholar
• Hatheway CL. Toxigenic clostridia. Clinical Microbiology Reviews. 1990;3(1):66–98.
   PubMed Web of Science ®Google Scholar
• Peck MW. Biology and Genomic Analysis of Clostridium botulinum. Adv Microb Physiol. 2009;55:183–320.
   PubMed Web of Science ®Google Scholar
• Shukla HD, Sharma SK. Clostridium botulinum: a bug with beauty and weapon. Crit Rev Microbiol. 2005;31(1):11–18.
   PubMed Web of Science ®Google Scholar
• Nigam P, Nigam A. Botulinum toxin. Indian J Dermatol. 2010;55(1):8–14.
   PubMedGoogle Scholar
• Dorizas A, Krueger N, Sadick NS. Aesthetic uses of the botulinum toxin. Dermatol Clin. 2014;32(1):23–36.
   PubMed Web of Science ®Google Scholar
• Chen S. Clinical uses of botulinum neurotoxins: current indications, limitations and future developments. Toxins (Basel). 2012;4:913–939.
   PubMed Web of Science ®Google Scholar
• Rossetto O, Pirazzini M, Montecucco C. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nature Rev Microbiol. 2014;12(8):535–549.
   PubMed Web of Science ®Google Scholar
• Lund BM, Peck M. Clostridium botulinum. In: Lund BM, Baird-Parker AC, GW Gould, editors. The Microbiological Safety and Quality of Food. Maryland, MD, USA: Aspen; 2000. pp. 1057–1109.
   Google Scholar
• Erbguth FJ. From poison to remedy: the chequered history of botulinum toxin. J Neural Transm. 2008;115(4):559–565.
   PubMed Web of Science ®Google Scholar
• Kerner J Neue beobachtungen über die in württemberg so häufig vorfallenden tödlichen vergiftungen durch den genuss geräucherter würste. Tübingen, Oisander 1820.
   Google Scholar
• Erbguth FJ, Naumann M. Historical aspects of botulinum toxin: justinus Kerner (1786-1862) and the sausage poison. Neurology. 1999;53(8):1850.
   PubMed Web of Science ®Google Scholar
• Erbguth FJ. Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov Disord. 2004;19(S8):S2–6.
   PubMedGoogle Scholar
• van Ermengem E. A New Anaerobic Bacillus and Its Relation to Botulism. Clin Infect Dis. 1979;1(4):701–719.
   Google Scholar
• Winslow CE, Broadhurst J, Buchanan RE, et al. THE families and genera of the bacteria preliminary report of the committee of the society of American bacteriologists on characterization and classification of bacterial types. J Bacteriol. 1917;2(5):505.
   PubMedGoogle Scholar
• Burke GS. The Occurrence of Bacillus botulinus in Nature. J Bacteriol. 1919;4(5):541.
   PubMedGoogle Scholar
• Sommer H, Nealon PJ, Snipe PT. Studies on Botulinum Toxin: 4. Dialysis Experiments. J Infect Dis. 1928;43(2):161–166.
   Google Scholar
• Lamanna C, Eklund HW, McElroy OE. Botulinum Toxin (Type A); Including a Study of Shaking with Chloroform as a Step in the Isolation Procedure. J Bacteriol. 1946;52(1):1.
   Web of Science ®Google Scholar
• Burgen ASV, Dickens F, Zatman LJ. The action of botulinum toxin on the neuromuscular junction. Journal of Physiology. 1949;109(1–2):10–24.
   PubMed Web of Science ®Google Scholar
• Schiavo GG, Benfenati F, Poulain B, et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature. 1992;359(6398):832–835.
   PubMed Web of Science ®Google Scholar
• Schantz EJ, Johnson EA. Botulinum toxin: the story of its development for the treatment of human disease. Perspect Biol Med. 1997;40(3):317–327.
   PubMed Web of Science ®Google Scholar
• Pellett S. Learning from the past: historical aspects of bacterial toxins as pharmaceuticals. Curr Opin Microbiol. 2012;15(3):292–299.
   PubMed Web of Science ®Google Scholar
• Scott AB. Botulinum toxin injection to correct strabism. Trans Am Ophthalmol Soc. 1979;79:924–927.
   Google Scholar
• Scott AB. Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery. Ophthalmol. 1980;87(10):1044–1049.
   PubMed Web of Science ®Google Scholar
• Schantz EJ, Scott AB. Use of crystalline type a botulinum toxin in medical research. In: Lewis E, editor. Biomedical Aspects of Botulism. San Diego, CA: Academic Press; 1981. pp. 143–150.
   Google Scholar
• Ting PT, Freiman A. The story of Clostridium botulinum: from food poisoning to Botox. Clin Med. 2004;4:258–261.
   PubMed Web of Science ®Google Scholar
• Monheit GD, Pickett A. AbobotulinumtoxinA: a 25-year history. Aesthet Surg J. 2017;37(suppl_1):S4–11.
   PubMedGoogle Scholar
• Choudhury S, Baker MR, Chatterjee S, et al. Botulinum toxin: an update on pharmacology and newer products in development. Toxins (Basel). 2021;13(1):58.
   PubMed Web of Science ®Google Scholar
• Frevert J, Ahn KY, Park MY, et al. Comparison of botulinum neurotoxin type a formulations in Asia. 2018;11:327.
   Google Scholar
• Duplantier J, A DK, Bavari C, et al. Searching for therapeutics against botulinum neurotoxins: a true challenge for drug discovery. Curr Top Med Chem. 2016;16(21):2330–2349.
   PubMed Web of Science ®Google Scholar
• Hill KK, Smith TJ, Helma CH, et al. Genetic diversity among botulinum neurotoxin-producing clostridial strains. J Bacteriol. 2007;189(3):818–832.
   PubMed Web of Science ®Google Scholar
• Holdeman LV, Brooks JB. Variation among strains of Clostridium botulinum and related clostridia. In: Herzberg M, editor. Proceedings of the 1st US-Japan Conference on Toxic Microorganisms. Washington, DC.: U.S. Government Printing Office; 1970. p. 278–286.
   Google Scholar
• Collins C, East E. Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins. J Appl Microbiol. 1998;84:5–17.
   PubMed Web of Science ®Google Scholar
• Peck MW, Smith TJ, Anniballi F, et al. Historical perspectives and guidelines for botulinum neurotoxin subtype nomenclature. Toxins (Basel). 2017;9(1):38.
   PubMed Web of Science ®Google Scholar
• Hill KK, Smith TJ. Genetic Diversity Within Clostridium botulinum Serotypes, Botulinum Neurotoxin Gene Clusters and Toxin Subtypes. Curr Top Microbiol Immunol. 2012;364:1–20.
   Web of Science ®Google Scholar
• Suen JC, Hatheway CL, Steigerwalt AG, et al. Clostridium argentinense sp. nov.: a genetically homogeneous group composed of all strains of Clostridium botulinum toxin type G and some nontoxigenic strains previously identified as Clostridium subterminale or Clostridium hastiforme. Int J Bacteriol. 1988;38(4):375–381.
   Google Scholar
• Zhang S, Masuyer G, Zhang J, et al. Identification and characterization of a novel botulinum neurotoxin. Nat Commun. 2017;8(1):1–10.
   PubMedGoogle Scholar
• Dover N, Barash JR, Hill KK, et al. Molecular characterization of a novel botulinum neurotoxin type H gene. J Infect Dis. 2014;209(2):192–202.
   PubMed Web of Science ®Google Scholar
• Kalb SR, Baudys J, Raphael BH, et al. Functional Characterization of Botulinum Neurotoxin Serotype H as a Hybrid of Known Serotypes F and a (BoNT F/A). Anal Chem. 2015;87(7):3911–3917.
   PubMed Web of Science ®Google Scholar
• Maslanka SE, Lúquez C, Dykes JK, et al. A novel botulinum neurotoxin, previously reported as Serotype H, has a hybrid-like structure with regions of similarity to the structures of serotypes a and F and is neutralized with Serotype a antitoxin. J Infect Dis. 2016;213(3):379–385.
   PubMed Web of Science ®Google Scholar
• Leuchs J. Beiträge zur Kenntnis des Toxins und Antitoxins des Bacillus botulinus. Zeitschrift für Hygiene und Infektionskrankheiten. 1910;76(1):55–84.
   Google Scholar
• Smith TJ, Lou J, Geren IN, et al. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun. 2005;73(9):5450–5457.
   PubMed Web of Science ®Google Scholar
• Rossetto O, Montecucco C. Tables of Toxicity of Botulinum and Tetanus Neurotoxins. Toxins (Basel). 2019;11(12):686.
   PubMed Web of Science ®Google Scholar
• Franciosa G, Floridi F, Maugliani A, et al. Differentiation of the gene clusters encoding botulinum neurotoxin type a complexes in Clostridium botulinum type A, Ab, and A(B) strains. Appl Environ Microbiol. 2004;70(12):7192–7199.
   PubMed Web of Science ®Google Scholar
• Moriishi K, Koura M, Fujii N, et al. Molecular cloning of the gene encoding the mosaic neurotoxin, composed of parts of botulinum neurotoxin types C1 and D, and PCR detection of this gene from Clostridium botulinum type C organisms. Appl Environ Microbiol. 1996;62(2):662.
   PubMed Web of Science ®Google Scholar
• Moriishi K, Koura M, Abe N, et al. Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms 1. Biochimica Et Biophysica Acta (BBA) - Gene Structure and Expression. 1996;1307(2):123–126.
   PubMedGoogle Scholar
• Nakamura K, Kohda T, Umeda K, et al. Characterization of the D/C mosaic neurotoxin produced by Clostridium botulinum associated with bovine botulism in Japan. Vet Microbiol. 2010;140:147–154.
   PubMed Web of Science ®Google Scholar
• Schleberger C, Hochmann H, Barth H, et al. Structure and action of the binary C2 toxin from Clostridium botulinum. J Mol Biol. 2006;364:705–715.
   PubMed Web of Science ®Google Scholar
• Sakaguchi Y, Suzuki T, Yamamoto Y, et al. Genomics of Clostridium botulinum group III strains. Res Microbiol. 2015;166:318–325.
   PubMed Web of Science ®Google Scholar
• Zornetta I, Azarnia Tehran D, Arrigoni G, et al. The first non Clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain. Sci Rep. 2016;6.
   PubMed Web of Science ®Google Scholar
• Zhang S, Lebreton F, Mansfield MJ, et al. Identification of a Botulinum Neurotoxin-like Toxin in a Commensal Strain of Enterococcus faecium. Cell Host & Microbe. 2018;23(2):169–176.e6.
   PubMed Web of Science ®Google Scholar
• Brunt J, Carter AT, Stringer SC, et al. Identification of a novel botulinum neurotoxin gene cluster in Enterococcus. FEBS Lett. 2018;592(3):310–317.
   PubMed Web of Science ®Google Scholar
• Wentz TG, Muruvanda T, Lomonaco S, et al. Closed genome sequence of Chryseobacterium piperi strain CTMT/ATCC BAA- 1782, a Gram-negative bacterium with clostridial neurotoxin-like coding sequences. Genome Announc. 2017; 5(48).
   PubMedGoogle Scholar
• Eleopra R, Tugnoli V, Rossetto O, et al. Different time courses of recovery after poisoning with botulinum neurotoxin serotypes a and E in humans. Neurosci Lett. 1998;256:135–138.
   PubMed Web of Science ®Google Scholar
• Keller JE. Recovery from botulinum neurotoxin poisoning in vivo. Neuroscience. 2006;139(2):629–637.
   PubMed Web of Science ®Google Scholar
• Seddon HR. Bulbar Paralysis in Cattle Due to the Action of a Toxicogenic Bacillus, with a Discussion on the Relationship of the Condition to Forage Poisoning (Botulism). J Comp Pathol Ther. 1922;35:147–190.
   Google Scholar
• Skarin H, Håfström T, Westerberg J, et al. Clostridium botulinum group III: a group with dual identity shaped by plasmids, phages and mobile elements. BMC Genomics. 2011;12(1):185.
   PubMedGoogle Scholar
• Smith T, Williamson CHD, Hill K, et al. Botulinum neurotoxin-producing bacteria. Isn’t it time that we called a species a species? MBio. 2018;9(5).
   Web of Science ®Google Scholar
• Tamura K, Stecher G, Kumar S. MEGA11: molecular Evolutionary Genetics Analysis Version 11. Mol Biol Evol. 2021;38(7):3022–3027.
   PubMed Web of Science ®Google Scholar
• Janik E, Ceremuga M, Bijak JS, et al. Biological toxins as the potential tools for bioterrorism. Int J Mol Sci. 2019;20.
   PubMed Web of Science ®Google Scholar
• Carus WS. Bioterrorism and Biocrimes: the Illicit Use of Biological Agents Since 1900. . Washington DC, USA: Center for Counterproliferation Research, National Defense University; 2001. p. 209.
   Google Scholar
• U.K. Government. Schedule 5 Pathogens and toxins [Internet]. 2001 [cited 20 October 2022]. Available from: http://www.legislation.gov.uk/ukpga/2001/24/contents.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Bioterrorism Agents/Diseases [Internet]. 2018 [cited 20 October 2022]; Available from: https://emergency.cdc.gov/agent/agentlist-category.asp.
   Google Scholar
• Josko D. Botulin toxin: a weapon in terrorism. Clin. Lab Sci. 2004;17:30–34.
   Google Scholar
• Patocka J, Splino M, Merka V. Botulism and bioterrorism: how serious is this problem? Acta medica (Hradec Králové). Acta Medica (Hradec Kralove). 2005;48(1):23–28.
   PubMedGoogle Scholar
• Arnon SS, Schechter R, V IT, et al. Botulinum toxin as a biological weapon. JAMA. 2001;285:1059–1070.
   PubMed Web of Science ®Google Scholar
• Smith TJ, Roxas-Duncan V, Smith L. Botulinum neurotoxins as biothreat agents. J Bioterror Biodef. 2012;2:S2:003.
   Google Scholar
• Zilinskas RA. Iraq’s Biological Weapons. JAMA. 1997;278:418–424.
   PubMed Web of Science ®Google Scholar
• Villar RG, Elliott SP, Davenport KM. Botulism: the Many Faces of Botulinum Toxin and its Potential for Bioterrorism. Infect Dis Clin North Am. 2006;20:313–327.
   PubMed Web of Science ®Google Scholar
• Kazdobina IS. Stability of botulin toxins in solutions and beverages. Gig Sanit. 1995;1:9–12.
   Google Scholar
• Siegel LS. Destruction of Botulinum Toxins in Food and Water. In: Hauschild A, Dodds K, editors. Ecology and Control in Foods. 1st ed. Boca Raton: CRC Press; 1993. pp. 323–341.
   Google Scholar
• Cenciarelli O, Riley PW, Baka A. Biosecurity Threat Posed by Botulinum Toxin. Toxins (Basel). 2019;11(12):681.
   PubMed Web of Science ®Google Scholar
• Johnson EA, Montecucco C. Botulism. In: Andrew GE, editor. Handbook of Clinical Neurology. Vol. 91. Amsterdam, NL: Elsevier; 2008. p. 333–368. DOI:10.1016/S0072-9752(07)01511-4
   Google Scholar
• Centers for Disease Control and Prevention (CDC). National Botulism Surveillance Summary, 2017 [Internet]. [cited 20 Occtober 2022]. Available from: https://www.cdc.gov/botulism/surv/2017/index.html
   Google Scholar
• Gangarosa EJ, Donadio JA, Armstrong RW, et al. Botulism in the United States, 1899–1969. Am J Epidemiol. 1971;93(2):93–101.
   PubMed Web of Science ®Google Scholar
• Shapiro RL. Botulism in the United States: a clinical and epidemiologic review. Ann internal med. 1998;129(3):221–228.
   PubMed Web of Science ®Google Scholar
• Sobel J, Tucker N, Sulka A, et al. Foodborne Botulism in the United States, 1990–2000. Emerg Infect Dis. 2004;10(9):1606–1611.
   PubMed Web of Science ®Google Scholar
• Critchley EM. A comparison of human and animal botulism: a review. J R Soc Med. 1991;84(5):295.
   PubMed Web of Science ®Google Scholar
• Hughes JM, Blumenthal JR, Merson MH, et al. Clinical features of types a and B food-borne botulism. Ann Intern Med. 1981;95:442–445.
   PubMed Web of Science ®Google Scholar
• Lund BM, Peck MW. Heat resistance and recovery of spores of non-proteolytic Clostridium botulinum in relation to refrigerated, processed foods with an extended shelf-life. J Appl Bacteriol. 1994;76:115S–128S.
   Google Scholar
• Peck MW. Clostridium botulinum and the safety of refrigerated processed foods of extended durability. Trends Food Sci Technol. 1997;8:186–192.
   Web of Science ®Google Scholar
• McLauchlin J, Grant KA, Little CL. Food-borne botulism in the United Kingdom. J Public Health. 2006;28(4):337–342.
   Google Scholar
• International Commission on Microbiological Specifications for Foods (ICMSF). Clostridium botulinum. In: Roberts TA, Baird-Parker AC, Tompkin RB, editors. Microorganisms in Foods 5: characteristics of microbial pathogens. London, UK: Blackie Academic & Professional; 1996. p. 68–111.
   Google Scholar
• Carter AT, Peck MW. Genomes, neurotoxins and biology of Clostridium botulinum Group I and Group II. Res Microbiol. 2015;166(4):303–317.
   PubMed Web of Science ®Google Scholar
• Peck MW. Clostridium botulinum and the safety of minimally heated, chilled foods: an emerging issue? J Appl Microbiol. 2006;101(3):556–570.
   PubMed Web of Science ®Google Scholar
• Peck MW, Stringer SC. The safety of pasteurised in-pack chilled meat products with respect to the foodborne botulism hazard. Meat Sci. 2005;70(3):461–475.
   PubMed Web of Science ®Google Scholar
• Stumbo CR, Purohit KS, Ramakrishnan TV. Thermal process lethality guide for low‐acid foods in metal containers. J Food Sci. 1975;40(6):1316–1323.
   Web of Science ®Google Scholar
• Lindström M, Kiviniemi K, Korkeala H. Hazard and control of group II (non-proteolytic) Clostridium botulinum in modern food processing. Int J Food Microbiol. 2006;108:92–104.
   PubMed Web of Science ®Google Scholar
• Juliao PC, Maslanka S, Dykes J, et al. National outbreak of type a foodborne botulism associated with a widely distributed commercially canned hot dog chili sauce. Clin Infect Dis. 2013;56(3):376–382.
   PubMed Web of Science ®Google Scholar
• Rocke TE, Samuel MD. Water and Sediment Characteristics Associated with Avian Botulism Outbreaks in Wetlands. J Wildl Manage. 1999;63(4):1249.
   Web of Science ®Google Scholar
• Espelund M, Klaveness D. Botulism outbreaks in natural environments – an update. Front Microbiol. 2014;5:287.
   PubMed Web of Science ®Google Scholar
• Duncan RM, Jensen WI. A relationship between avian carcasses and living invertebrates in the epizootiology of avian botulism. J Wildl Dis. 1976;12:116–126.
   PubMedGoogle Scholar
• Johnson AL, McAdams-Gallagher SC, Aceto H. Accuracy of a Mouse Bioassay for the Diagnosis of Botulism in Horses. J Vet Intern Med. 2016;30:1293–1299.
   PubMed Web of Science ®Google Scholar
• Cagan E, Peker E, Dogan M, et al. Infant Botulism. Eurasian J Med. 2010;42(2):92.
   PubMedGoogle Scholar
• Fox CK, Keet CA, Strober JB. Recent advances in infant botulism. Pediatr Neurol. 2005;32(3):149–154.
   PubMed Web of Science ®Google Scholar
• Tanzi MG, Gabay MP. Association between honey consumption and infant botulism. Pharmacotherapy. 2002;22(11):1479–1483.
   PubMed Web of Science ®Google Scholar
• Arnon SS, Midura TF, Damus K, et al. Honey and other environmental risk factors for infant botulism. J Paediatr. 1979;94(2):331–336.
   PubMed Web of Science ®Google Scholar
• Aureli P, Franciosa G, Fenicia L. Infant botulism and honey in Europe: a commentary. Pediatr Infect Dis J. 2002;21(9):866–868.
   PubMed Web of Science ®Google Scholar
• Brett MM, McLauchlin J, Harris A, et al. A case of infant botulism with a possible link to infant formula milk powder: evidence for the presence of more than one strain of Clostridium botulinum in clinical specimens and food. J Med Microbiol. 2005;54:769–776.
   PubMed Web of Science ®Google Scholar
• Nevas M, Lindstrom M, Virtanen A, et al. Infant botulism acquired from household dust presenting as sudden infant death syndrome. J Clin Microbiol. 2005;43(1):511–513.
   PubMed Web of Science ®Google Scholar
• Midura TF, Arnon SS. Infant botulism. Identification of Clostridium botulinum and its toxins in faeces. Lancet. 1976;308(7992):934–936.
   Google Scholar
• Koepke R, Sobel J, Arnon SS. Global occurrence of infant botulism, 1976-2006. Pediatrics. 2008;122(1):122.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). National Botulism Surveillance [Internet]. 2018 [cited 20th October 2022]. Available from: https://www.cdc.gov/botulism/surveillance.html.
   Google Scholar
• Davis JB, Mattman LH, Wiley M. Clostridium botulinum in a Fatal Wound Infection. J Am Med Assoc. 1951;146:646–648.
   PubMed Web of Science ®Google Scholar
• Merson MH, Dowell VR. Epidemiologic, Clinical and Laboratory Aspects of Wound Botulism. N Engl J Med. 1973;289:1005–1010.
   PubMed Web of Science ®Google Scholar
• Elston HR, Wang M, Loo LK. Arm abscesses caused by Clostridium botulinum. J Clin Microbiol. 1991;29:2678.
   PubMed Web of Science ®Google Scholar
• Brett MM, Hood J, Brazier JS, et al. Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom. Epidemiol Infect. 2005;133:575–582.
   PubMed Web of Science ®Google Scholar
• Kuehn B. Wound Botulism Outbreak. JAMA. 2019;321(6):538.
   Web of Science ®Google Scholar
• Werner SB, Passaro D, McGee J, et al. Wound Botulism in California, 1951–1998: recent Epidemic in Heroin Injectors. Clin Infect Dis. 2000;31:1018–1024.
   PubMed Web of Science ®Google Scholar
• Passaro DJ, Werner SB, McGee J, et al. Wound botulism associated with black tar heroin among injecting drug users. J Am Med Assoc. 1998;279:859–863.
   PubMed Web of Science ®Google Scholar
• McCroskey LM, Hatheway CL. Laboratory findings in four cases of adult botulism suggest colonization of the intestinal tract. J Clin Microbiol. 1988;26(5):1052.
   PubMed Web of Science ®Google Scholar
• Fenicia L, Anniballi F, Aureli P. Intestinal toxemia botulism in Italy, 1984-2005. Eur J Clin Microbiol Infect Dis. 2007;26:385–394.
   PubMed Web of Science ®Google Scholar
• Harris RA, Anniballi F, Austin JW. Adult Intestinal Toxemia Botulism. Toxins (Basel). 2020;12(2):81./81.
   Web of Science ®Google Scholar
• Bakheit AMO, Ward CD, McLellan DL. Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases [3]. J Neurol Neurosurg Psychiatry. 1997;62(2):198.
   PubMed Web of Science ®Google Scholar
• Chertow DS, Tan ET, Maslanka SE, et al. Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. JAMA. 2006;296(20):2476–2479.
   PubMed Web of Science ®Google Scholar
• Crowner BE, Brunstrom JE, Racette BA. Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patient. Clin Neuropharmacol. 2007;30(5):310–313.
   PubMed Web of Science ®Google Scholar
• Holzer E. Botulism caused by inhalation. Medizinische Klin. 1962;57:1735–1738.
   PubMedGoogle Scholar
• Park JB, Simpson LL. Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component. Infect Immun. 2003;71(3):1147–1154.
   PubMed Web of Science ®Google Scholar
• Pitt MLM, LeClaire RD. Pathogenesis by Aerosol. In: Lebeda F , Korch G, Lindler L, editors. Biological Weapons Defense. Totowa, NJ: Humana Press; 2005. pp. 65–78.
   Google Scholar
• O’Horo JC, Harper EP, El Rafei A, et al. Efficacy of Antitoxin Therapy in Treating Patients with Foodborne Botulism: a Systematic Review and Meta-analysis of Cases, 1923-2016. Clin Infect Dis. 2017;66:S43–56.
   PubMed Web of Science ®Google Scholar
• Rao AK, Sobel J, Chatham-Stephens K, et al. Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021. MMWR Recommendations Rep. 2021;70(2):1.
   PubMed Web of Science ®Google Scholar
• Yu PA, Lin NH, Mahon BE, et al. Safety and Improved Clinical Outcomes in Patients Treated with New Equine-Derived Heptavalent Botulinum Antitoxin. Clin Infect Dis. 2018;66(suppl_1):S57–64.
   Google Scholar
• Barker D, Gillum KT, Niemuth NA, et al. Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs. PLoS ONE. 2019;14:e0222670. DOI:10.1371/journal.pone.0222670
   Web of Science ®Google Scholar
• Lonati D, Schicchi A, Crevani M, et al. Foodborne Botulism: clinical diagnosis and medical treatment. Toxins (Basel). 2020;12(8):509.
   PubMed Web of Science ®Google Scholar
• Ben David A, Barnea A, Torgeman A, et al. Immunologic and Protective Properties of Subunit- vs. Whole Toxoid-Derived Anti-Botulinum Equine Antitoxin. Vaccines. 2022;10(9):1522.
   Web of Science ®Google Scholar
• US Food and Drug Administration (FDA). Approval History, Letters, Reviews, and Related Documents - BAT (Botulism Antitoxin Heptavalent (A B, C D, E F, G)) (Equine) [Internet]. 2013 [cited 20th October 2022]; Available from: https://www.fda.gov/vaccines-blood-biologics/approved-blood-products/bat-botulism-antitoxin-heptavalent-b-c-d-e-f-g-equine
   Google Scholar
• Atassi MZ. Immune recognition of BoNTs a and B: how anti-toxin antibodies that bind to the heavy chain obstruct toxin action. Toxicon. 2009;54(5):600–613.
   PubMed Web of Science ®Google Scholar
• Tacket CO, Shandera WX, Mann JM, et al. Equine antitoxin use and other factors that predict outcome in type a foodborne botulism. Am j med. 1984;76(5):794–798.
   PubMed Web of Science ®Google Scholar
• Black RE, Gunn RA. Hypersensitivity reactions associated with botulinal antitoxin. Am j med. 1980;69(4):567–570.
   PubMed Web of Science ®Google Scholar
• Pirazzini M, Rossetto O. Challenges in searching for therapeutics against Botulinum Neurotoxins. Expert Opin Drug Discov. 2017;12(5):497–510.
   PubMed Web of Science ®Google Scholar
• Schussler E, Sobel J, Hsu J, et al. Workgroup Report by the Joint Task Force Involving American Academy of Allergy, Asthma & Immunology (AAAAI); Food Allergy, Anaphylaxis, Dermatology and Drug Allergy (FADDA) (Adverse Reactions to Foods Committee and Adverse Reactions to Drugs, Biologicals, and Latex Committee); and the Centers for Disease Control and Prevention Botulism Clinical Treatment Guidelines Workgroup—Allergic Reactions to Botulinum Antitoxin: a Systematic Review. Clin Infect Dis an off Publ Infect Dis Soc Am. 2018;66:S65.
   Web of Science ®Google Scholar
• Arnon SS, Schechter R, Maslanka SE, et al. Human Botulism Immune Globulin for the Treatment of Infant Botulism. N Engl J Med. 2006;354(5):462–471.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration (FDA). BabyBIG [Internet]. 2003 [cited 20th October 2022]; Available from: https://www.fda.gov/vaccines-blood-biologics/approved-blood-products/babybig
   Google Scholar
• Fenicia L, Anniballi F. Infant botulism. Ann Ist Super Sanita. Annali dell’Istituto superiore di sanita. 2009;45(2):134–146.
   PubMed Web of Science ®Google Scholar
• Payne JR, Khouri JM, Jewell NP, et al. Efficacy of Human Botulism Immune Globulin for the Treatment of Infant Botulism: the First 12 Years Post Licensure. J Paediatr. 2018;193:172–177.
   PubMed Web of Science ®Google Scholar
• Schulte M, Hamsen U, Schildhauer TA, et al. Effective and rapid treatment of wound botulism, a case report. BMC Surg. 2017;17(1):103.
   PubMedGoogle Scholar
• Brook I. Infant botulism. Journal of Perinatology. 2007;27(3):175–180.
   PubMed Web of Science ®Google Scholar
• Arnon SS. Botulism as an intestinal toxemia. In: S BM, RJ PD GH GR, editors. Infections of the gastrointestinal tract. New York: Raven Press; 1995. pp. 257–271.
   Google Scholar
• Fagan RP, Neil KP, Sasich R, et al. Initial Recovery and Rebound of Type F Intestinal Colonization Botulism After Administration of Investigational Heptavalent Botulinum Antitoxin. Clin Infect Dis. 2011;53(9):e125–8.
   PubMed Web of Science ®Google Scholar
• Rasetti-Escargueil C, Popoff MR. Antibodies and vaccines against botulinum toxins: available measures and novel approaches. Toxins (Basel). 2019;11:528. DOI:10.3390/toxins11090528
   PubMed Web of Science ®Google Scholar
• Thanongsaksrikul J, Chaicumpa W. Botulinum neurotoxins and botulism: a novel therapeutic approach. Toxins (Basel). 2011;3(5):469–488.
   PubMed Web of Science ®Google Scholar
• Nowakowski A, Wang C, Powers DB, et al. Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc Natl Acad Sci, USA. 2002;99(17):11346–11350.
   PubMed Web of Science ®Google Scholar
• Fan Y, Garcia-Rodriguez C, Lou J, et al. A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes. PLoS ONE. 2017;12:e0174187. DOI:10.1371/journal.pone.0174187
   PubMed Web of Science ®Google Scholar
• Snow DM, Riling K, Kimbler A, et al. Safety and Pharmacokinetics of a Four Monoclonal Antibody Combination Against Botulinum C and D Neurotoxins. Antimicrob Agents Chemother. 2019;63:e01270–19. DOI:10.1128/AAC.01270-19
   PubMed Web of Science ®Google Scholar
• Matsumura T, Amatsu S, Misaki R, et al. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B. Toxins (Basel). 2020;12(5):12.
   Web of Science ®Google Scholar
• Garcia-Rodriguez C, Razai A, Geren IN, et al. A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes. Toxins (Basel). 2018;10(3):10.
   Web of Science ®Google Scholar
• Godakova SA, Noskov AN, Vinogradova ID, et al. Camelid VHHs Fused to Human Fc Fragments Provide Long Term Protection Against Botulinum Neurotoxin a in Mice. Toxins (Basel). 2019;11:464. DOI:10.3390/toxins11080464
   PubMed Web of Science ®Google Scholar
• Mukherjee J, Ondeck CA, Tremblay JM, et al. Intramuscular delivery of formulated RNA encoding six linked nanobodies is highly protective for exposures to three Botulinum neurotoxin serotypes. Sci Rep. 2022;12(1):12.
   PubMed Web of Science ®Google Scholar
• Derkaev AA, Ryabova EI, Esmagambetov IB, et al. rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type a prophylaxis. Front Microbiol. 2022;13.
   PubMed Web of Science ®Google Scholar
• Rusnak JM, Smith LA. Botulinum neurotoxin vaccines: past history and recent developments. Hum Vaccines. 2009;5(12):794–805.
   PubMed Web of Science ®Google Scholar
• Smith LA. Botulism and vaccines for its prevention. Vaccine. 2009;27 Suppl 4:D33–9. DOI:10.1016/j.vaccine.2009.08.059
   PubMedGoogle Scholar
• Graham R, Thorp F. The Effect of Formalin on Botulinum Toxins A, B and C. J Immunol. 1929;16(4):391–401.
   Google Scholar
• Keller JE. Characterization of new formalin-detoxified botulinum neurotoxin toxoids. Clin Vaccine Immunol. 2008;15(9):1374–1379.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Notice of CDC’s discontinuation of investigational pentavalent (ABCDE) botulinum toxoid vaccine for workers at risk for occupational exposure to botulinum toxins. Morb Mortal Wkly Rep. 2011;60:1454–1455.
   PubMedGoogle Scholar
• Sundeen G, Barbieri JT. Vaccines against botulism. Toxins (Basel). 2017;9(9):268.
   PubMed Web of Science ®Google Scholar
• Hatami F, Shokouhi S, Mardani M, et al. Early recovery of botulism: one decade of experience. Clin Toxicol. 2021;59(7):628–632.
   PubMed Web of Science ®Google Scholar
• De Paiva A, Meunier FA, Molgó J, et al. Functional repair of motor endplates after botulinum neurotoxin type a poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Nat Acad Sci. 1999;96(6):3200–3205.
   PubMed Web of Science ®Google Scholar
• Holland RL, Brown MC. Nerve growth in botulinum toxin poisoned muscles. Neuroscience. 1981;6(6):1167–1179.
   PubMed Web of Science ®Google Scholar
• Adler M, Franz DR. Toxicity of botulinum neurotoxin by inhalation: implications in bioterrorism. In: Salem H, Katz S, editors. Aerobiology: the Toxicology of Airborne Pathogens and Toxins. Cambridge, U.K: Royal Society of Chemistry; 2016. pp. 167–185.
   Google Scholar
• Meunier FA, Schiavo G, Molgó J. Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J Physiol Paris. 2002;96(1–2):105–113.
   PubMedGoogle Scholar
• Tsai YC, Maditz R, Kuo C-L, et al. Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system. Proc Nat Acad Sci. 2010;107(38):16554–16559.
   PubMed Web of Science ®Google Scholar
• Tsai YC, Kotiy A, Kiris E, et al. Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type a intoxication. Proc Nat Acad Sci. 2017;114(26):E5158–66.
   PubMed Web of Science ®Google Scholar
• Sen E, Kota KP, Panchal RG, et al. Screening of a Focused Ubiquitin-Proteasome Pathway Inhibitor Library Identifies Small Molecules as Novel Modulators of Botulinum Neurotoxin Type a Toxicity. Front Pharmacol. 2021;12:2659.
   Web of Science ®Google Scholar
• Rao AK, Lin NH, Jackson KA, et al. Clinical Characteristics and Ancillary Test Results Among Patients with Botulism—United States, 2002–2015. Clin Infect Dis. 2017;66(suppl_1):S4–10.
   PubMedGoogle Scholar
• Chatham-Stephens K, Fleck-Derderian S, Johnson SD, et al. Clinical Features of Foodborne and Wound Botulism: a Systematic Review of the Literature, 1932-2015. Clin Infect Dis. 2017;66:S11–6.
   PubMed Web of Science ®Google Scholar
• Louis ME S, Peck SHS, Bowering D, et al. Botulism from chopped garlic: delayed recognition of a major outbreak. Ann Intern Med. 1988;108:363–368.
   PubMed Web of Science ®Google Scholar
• Maslanka SE, Solomon HM, Sharma S, et al. Clostridium botulinum and its toxins. In: Tortorello M, F Downes, S Doores, K Ito, and Y Salfinger, editors. Compendium of methods for the microbiological examination of foods . Washington, DC: American Public Health Association; 2013. p. Chapter 32:1–11. DOI:10.2105/MBEF.0222.037
   Google Scholar
• Solomon HM, Lilly TJ. Chapter 17: Clostridium Botulinum. In: Jackson GJ , Merker RI, Bandler R, editors. Bacteriological Analytical Manual. 8th Ed. College Park, MD, USA: U.S. Food and Drug Administration (FDA), Centre for Food Safety and Applied Nutrition; 2001. https://www.fda.gov/food/laboratory-methods-food/bam-chapter-17-clostridium-botulinum
   Google Scholar
• Lindström M, Korkeala H. Laboratory diagnostics of botulism. Clin. Clinical Microbiology Reviews. 2006;19(2):298–314.
   PubMed Web of Science ®Google Scholar
• Taylor K. Botulinum toxin testing on animals is still a Europe-wide issue. ALTEX. 2019;36(1):81–90.
   PubMedGoogle Scholar
• Kakinuma H, Maruyama H, Yamakawa K, et al. Application of nested polymerase chain reaction for the rapid diagnosis of infant botulism type B. Pediatr Int. 1997;39(3):346–348.
   Google Scholar
• De Medici D, Anniballi F, Wyatt GM, et al. Multiplex PCR for Detection of Botulinum Neurotoxin-Producing Clostridia in Clinical, Food, and Environmental Samples. Appl Environ Microbiol. 2009;75(20):6457.
   PubMed Web of Science ®Google Scholar
• Szabo EA, Pemberton JM, Gibson AM, et al. Application of PCR to a clinical and environmental investigation of a case of equine botulism. J Clin Microbiol. 1994;32(8):1986–1991.
   PubMed Web of Science ®Google Scholar
• Chellapandi P, Prisilla A. PCR-based molecular diagnosis of botulism (types C and D) outbreaks in aquatic birds. Ann Microbiol. 2018;68(12):835–849.
   Web of Science ®Google Scholar
• Cai S, Singh BR, Sharma S. Botulism diagnostics: from clinical symptoms to in vitro assays. Crit Rev Microbiol. 2007;33(2):109–125.
   PubMed Web of Science ®Google Scholar
• Thirunavukkarasu N, Johnson E, Pillai S, et al. Botulinum Neurotoxin Detection Methods for Public Health Response and Surveillance. Front Bioeng Biotechnol. 2018;6:80.
   PubMed Web of Science ®Google Scholar
• Wictome M, Newton KA, Jameson K, et al. Development of in vitro assays for the detection of botulinum toxins in foods. FEMS Immunology & Medical Microbiology. 1999;24(3):319–323.
   PubMedGoogle Scholar
• Cheng LW, Land KM, Stanker LH. Chapter 1: Presence of Botulinum Neurotoxins in Food and Other Biological Samples. In: Morse SA, editor. Bioterrorism. Online Edition. London, UK: InTechOpen; 2012. p. 1–16. DOI:10.5772/33638
   Google Scholar
• Singh AK, Stanker LH, Sharma SK. Botulinum neurotoxin: where are we with detection technologies? Crit Rev Microbiol. 2013;39(1):43–56.
   PubMed Web of Science ®Google Scholar
• Čapek P, Dickerson TJ. Sensing the deadliest toxin: technologies for botulinum neurotoxin detection. Toxins (Basel). 2010;2(1):24–53.
   PubMed Web of Science ®Google Scholar
• Fernández-Salas E, Wang J, Molina Y, et al. Botulinum Neurotoxin Serotype a Specific Cell-Based Potency Assay to Replace the Mouse Bioassay. PLoS ONE. 2012;7(11):e49516.
   PubMed Web of Science ®Google Scholar
• Pharma M. Press Release: alternative Test Method for Botulinum Neurotoxin Now Approved in Europe [Internet]. 2015 [cited 20th October 2022]; Available from: https://www.merz.com/blog/news/alternative-test-method-for-botulinum-neurotoxin-now-approved-in-europe/
   Google Scholar
• Ipsen Inc. Press Release: ipsen’s Cell-Based Assay Receives Approvals in the E.U. and Switzerland for its Botulinum Toxin [Internet]. 2018 [cited 20th October 2022]; Available from: https://www.ipsen.com/websites/IPSENCOM-PROD/wp-content/uploads/2018/08/28165732/00-IAW-ONLINE-POSITION-STATEMENT_Ipsens-CBA-implementation-2018-08-27.pdf
   Google Scholar
• Pellett S. Progress in Cell Based Assays for Botulinum Neurotoxin Detection. Curr Top Microbiol Immunol. 2013;364:257–285.
   PubMed Web of Science ®Google Scholar
• Koh C-Y, Schaff UY, Piccini ME, et al. Centrifugal microfluidic platform for ultrasensitive detection of botulinum toxin. Anal Chem. 2015;87(2):922–928.
   PubMed Web of Science ®Google Scholar
• Halliwell J, Gwenin C. A label free colorimetric assay for the detection of active botulinum neurotoxin type a by SNAP-25 conjugated colloidal gold. Toxins (Basel). 2013;5(8):1381–1391.
   PubMed Web of Science ®Google Scholar
• Patel K, Halevi S, Melman P, et al. A novel surface plasmon resonance biosensor for the rapid detection of botulinum neurotoxins. Biosens (Basel). 2017;7(4):32.
   PubMedGoogle Scholar
• Savage AC, Buckley N, Halliwell J, et al. Botulinum neurotoxin serotypes detected by electrochemical impedance spectroscopy. Toxins (Basel). 2015;7(5):1544–1555.
   PubMed Web of Science ®Google Scholar
• Hobbs RJ, Thomas CA, Halliwell J, et al. Rapid Detection of Botulinum Neurotoxins—A Review. Toxins (Basel). 2019;11(7):11.
   PubMed Web of Science ®Google Scholar
• Smith TJ, Hill KK, Raphael BH. Historical and current perspectives on Clostridium botulinum diversity. Res Microbiol. 2015;166(4):290–302.
   PubMed Web of Science ®Google Scholar
• Lacy DB, Tepp W, Cohen AC, et al. Crystal structure of botulinum neurotoxin type a and implications for toxicity. Nat Struct Biol. 1998;5(10):898–902.
   PubMedGoogle Scholar
• Swaminathan S, Eswaramoorthy S. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat Struct Biol. 2000;7(8):693–699.
   PubMedGoogle Scholar
• Kumaran D, Eswaramoorthy S, Furey W, et al. Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation. J Mol Biol. 2009;386(1):233–245.
   PubMed Web of Science ®Google Scholar
• Dekleva ML, Dasgupta BR. Purification and characterization of a protease from Clostridium botulinum type a that nicks single-chain type a botulinum neurotoxin into the di-chain form. J Bacteriol. 1990;172(5):2498–2503.
   PubMed Web of Science ®Google Scholar
• Pettersen EF, Goddard TD, Huang CC, et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70–82.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Clark AW, DasGupta BR, et al. Role of the heavy and light chains of botulinum neurotoxin in neuromuscular paralysis. J Biol Chem. 1987;262(6):2660–2663.
   PubMed Web of Science ®Google Scholar
• Kriegistein KG, DasGupta BR, Henschen AH. Covalent structure of botulinum neurotoxin type A: location of sulfhydryl groups, and disulfide bridges and identification of C-termini of light and heavy chains. Journal of Protein Chemistry. 1994;13(1):49–57.
   PubMedGoogle Scholar
• Montecucco C, Schiavo G. Structure and Function of Tetanus and Botulinum Neurotoxins. Q Rev Biophys. 1995;28(4):423–472.
   PubMed Web of Science ®Google Scholar
• Pirazzini M, Montecucco C, Rossetto O. Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update. Arch Toxicol. 2022;96(6):1521–1539.
   PubMed Web of Science ®Google Scholar
• Yao G, Zhang S, Mahrhold S, et al. N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin a. Nature Structural & Molecular Biology. 2016;23(7):656–662.
   PubMed Web of Science ®Google Scholar
• Muraro L, Tosatto S, Motterlini L, et al. The N-terminal half of the receptor domain of botulinum neurotoxin a binds to microdomains of the plasma membrane. Biochem Biophys Res Commun. 2009;380(1):76–80.
   PubMed Web of Science ®Google Scholar
• Montecucco C, Zanotti G. Botulinum neurotoxin A1 likes it double sweet. Nature Structural & Molecular Biology. 2016;23:619–621.
   PubMed Web of Science ®Google Scholar
• Rummel A. Two feet on the membrane: uptake of clostridial neurotoxins. Curr Top Microbiol Immunol. 2017;406:1–37.
   PubMed Web of Science ®Google Scholar
• Brunger AT, Breidenbach MA, Jin R, et al. Botulinum Neurotoxin Heavy Chain Belt as an Intramolecular Chaperone for the Light Chain. PLOS Pathog. 2007;3:e113.
   PubMed Web of Science ®Google Scholar
• Galloux M, Vitrac H, Montagner C, et al. Membrane interaction of botulinum neurotoxin a translocation (T) domain: the belt region is a regulatory loop for membrane interaction. J Biol Chem. 2008;283:27668–27676.
   PubMed Web of Science ®Google Scholar
• Fischer A, Montal M. Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function. Toxicon. 2013;75:101–107.
   PubMed Web of Science ®Google Scholar
• Gu S, Jin R. Assembly and Function of the Botulinum Neurotoxin Progenitor Complex. Curr Top Microbiol Immunol. 2013;364:21–44.
   PubMed Web of Science ®Google Scholar
• Barrett AJ, Rawlings ND. Types and families of endopeptidases. Biochem Soc Trans. 1991;19:707–715.
   PubMed Web of Science ®Google Scholar
• Gu S, Rumpel S, Zhou J, et al. Botulinum neurotoxin is shielded by NTNHA in an interlocked complex. Science. 2012;335:977–981.
   PubMed Web of Science ®Google Scholar
• Jacobson MJ, Lin G, Raphael B, et al. Analysis of neurotoxin cluster genes in Clostridium botulinum strains producing botulinum neurotoxin serotype a subtypes. Appl Environ Microbiol. 2008;74:2778–2786.
   PubMed Web of Science ®Google Scholar
• Sebaihia M, Peck MW, Minton NP, et al. Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall a and comparative analysis of the clostridial genomes. Genome Res. 2007;17(7):1082–1092.
   PubMed Web of Science ®Google Scholar
• Lee K, Gu S, Jin L, et al. Structure of a Bimodular Botulinum Neurotoxin Complex Provides Insights into Its Oral Toxicity. PLOS Pathogens. 2013;9(10):e1003690.
   PubMed Web of Science ®Google Scholar
• Fujinaga Y, Inoue K, Watanabe S, et al. The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin. Microbiology. 1997;143(12):3841–3847.
   PubMedGoogle Scholar
• Fujinaga Y, Inoue K, Nomura T, et al. Identification and characterization of functional subunits of Clostridium botulinum type a progenitor toxin involved in binding to intestinal microvilli and erythrocytes. FEBS Lett. 2000;467(2–3):179–183.
   PubMed Web of Science ®Google Scholar
• Matsumura T, Sugawara Y, Yutani M, et al. Botulinum toxin a complex exploits intestinal M cells to enter the host and exert neurotoxicity. Nat Commun. 2015;6(1):6.
   Google Scholar
• Matsumura T, Fujinaga Y. Functional Analysis of Botulinum Hemagglutinin (HA). Methods Mol Biol. 2020;2132:191–200.
   PubMedGoogle Scholar
• Jin Y, Takegahara Y, Sugawara Y, et al. Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins – differences in cell tropism and the mechanism of action between HA proteins of types a or B, and HA proteins of type C. Microbiology. 2009;155(1):35–45.
   PubMedGoogle Scholar
• Sugawara Y, Matsumura T, Takegahara Y, et al. Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin. J Cell Bio. 2010;189(4):691–700.
   PubMed Web of Science ®Google Scholar
• Lee K, Zhong X, Gu S, et al. Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin a complex. Science. 2014;344(6190):1405–1410.
   PubMed Web of Science ®Google Scholar
• Fujinaga Y, Popoff MR. Translocation and dissemination of botulinum neurotoxin from the intestinal tract. Toxicon. 2018;147:13–18.
   PubMed Web of Science ®Google Scholar
• Gustafsson R, Berntsson RP-A, Martínez-Carranza M, et al. Crystal structures of OrfX2 and P47 from a Botulinum neurotoxin OrfX-type gene cluster. FEBS Lett. 2017;591(22):3781–3792.
   PubMed Web of Science ®Google Scholar
• Lam K-H, Qi R, Liu S, et al. The hypothetical protein P47 of Clostridium botulinum E1 strain Beluga has a structural topology similar to bactericidal/permeability-increasing protein. Toxicon. 2018;147:19–26.
   PubMed Web of Science ®Google Scholar
• Inoue K, Fujinaga Y, Watanabe T, et al. Molecular composition of Clostridium botulinum type a progenitor toxins. Infect Immun. 1996;64(5):1589–1594.
   PubMed Web of Science ®Google Scholar
• Simpson L. The life history of a botulinum toxin molecule. Toxicon. 2013;68:40–59.
   PubMed Web of Science ®Google Scholar
• Montecucco C. How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem Sci. 1986;11(8):314–317.
   Web of Science ®Google Scholar
• Rummel A. Double Receptor Anchorage of Botulinum Neurotoxins Accounts for their Exquisite Neurospecificity. Curr Top Microbiol Immunol. 2013;364:61–90.
   PubMed Web of Science ®Google Scholar
• Pirazzini M, Rossetto O, Bolognese P, et al. Double anchorage to the membrane and intact inter-chain disulfide bond are required for the low pH induced entry of tetanus and botulinum neurotoxins into neurons. Cell Microbiol. 2011;13(11):1731–1743.
   PubMed Web of Science ®Google Scholar
• Cottone G, Chiodo L, Maragliano L, et al. In Silico Conformational Features of Botulinum Toxins A1 and E1 According to Intraluminal Acidification. Toxins (Basel). 2022;14(9):644. 2022. .
   PubMed Web of Science ®Google Scholar
• Moriyama Y, Futai M. H±atpase, a primary pump for accumulation of neurotransmitters, is a major constituent of brain synaptic vesicles. Biochem Biophys Res Commun. 1990;173:443–448.
   PubMed Web of Science ®Google Scholar
• Fischer A. Synchronized Chaperone Function of Botulinum Neurotoxin Domains Mediates Light Chain Translocation into Neurons. Curr Top Microbiol Immunol. 2013;364:115–137.
   PubMed Web of Science ®Google Scholar
• Koriazova LK, Montal M. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat Struct Biol. 2003;10(1):13–18.
   PubMedGoogle Scholar
• Hoch DH, Romero-Mira M, Ehrlich BE, et al. Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. Proc Nat Acad Sci. 1985;82(6):1692–1696.
   PubMed Web of Science ®Google Scholar
• Fischer A, Montal M. Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes. J Biol Chem. 2007;282:29604–29611.
   PubMed Web of Science ®Google Scholar
• Pirazzini M, Bordin F, Rossetto O, et al. The thioredoxin reductase-thioredoxin system is involved in the entry of tetanus and botulinum neurotoxins in the cytosol of nerve terminals. FEBS Lett. 2013;587(2):150–155.
   PubMed Web of Science ®Google Scholar
• Sutton RB, Fasshauer D, Jahn R, et al. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution. Nature. 1998;395(6700):347–353.
   PubMed Web of Science ®Google Scholar
• Jahn R, Scheller RH. Snares — engines for membrane fusion. Nat Rev Mol Cell Biol. 2006;7(9):631–643.
   PubMed Web of Science ®Google Scholar
• Südhof TC, Rizo J. Synaptic vesicle exocytosis. Cold Spring Harbor Perspect Biol. 2011;3(12):3.
   Web of Science ®Google Scholar
• Binz T. Clostridial Neurotoxin Light Chains: devices for SNARE Cleavage Mediated Blockade of Neurotransmission. Curr Top Microbiol Immunol. 2013;364:139–157.
   PubMed Web of Science ®Google Scholar
• Rossetto O, Schiavo G, Montecucco C, et al. SNARE motif and neurotoxins. Nature. 1994;372(6505):415–416.
   PubMed Web of Science ®Google Scholar
• Shoemaker CB, Oyler GA. Persistence of Botulinum neurotoxin inactivation of nerve function. Curr Top Microbiol Immunol. 2013;364:179–196.
   PubMed Web of Science ®Google Scholar
• Keller JE, Neale EA. The Role of the Synaptic Protein SNAP-25 in the Potency of Botulinum Neurotoxin Type a. J Biol Chem. 2001;276(16):13476–13482.
   PubMed Web of Science ®Google Scholar
• Pantano S, Montecucco C. The blockade of the neurotransmitter release apparatus by botulinum neurotoxins. Cell Mol Life Sci. 2014;71(5):793–811.
   PubMed Web of Science ®Google Scholar
• Pirazzini M, Rossetto O, Eleopra R, et al. Botulinum neurotoxins: biology, pharmacology, and toxicology. Pharmacol Rev. 2017;69:200–235.
   PubMed Web of Science ®Google Scholar
• Caleo M, Schiavo G. Central effects of tetanus and botulinum neurotoxins. Toxicon. 2009;54(5):593–599.
   PubMed Web of Science ®Google Scholar
• Restani L, Novelli E, Bottari D, et al. Botulinum neurotoxin a impairs neurotransmission following retrograde transynaptic transport. Traffic. 2012;13(8):1083–1089.
   PubMed Web of Science ®Google Scholar
• Marchand-Pauvert V, Aymard C, Giboin L-S, et al. Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin a. Journal of Physiology. 2013;591(4):1017.
   PubMed Web of Science ®Google Scholar
• Aymard C, Giboin L-S, Lackmy-Vallée A, et al. Spinal plasticity in stroke patients after botulinum neurotoxin a injection in ankle plantar flexors. Physiological Reports. 2013;1(6):e00173.
   PubMedGoogle Scholar
• Mazzocchio R, Caleo M. More than at the neuromuscular synapse: actions of botulinum neurotoxin a in the central nervous system. Neuroscientist. 2015;21(1):44–61.
   PubMed Web of Science ®Google Scholar
• Marinelli S, Vacca V, Ricordy R, et al. The Analgesic Effect on Neuropathic Pain of Retrogradely Transported botulinum Neurotoxin a Involves Schwann Cells and Astrocytes. PLoS ONE. 2012;7(10):e47977.
   PubMed Web of Science ®Google Scholar
• Luvisetto S. Botulinum Neurotoxins in Central Nervous System: an Overview from Animal Models to Human Therapy. Toxins (Basel). 2021;13(11):751.
   PubMed Web of Science ®Google Scholar
• Popoff MR, Marvaud J. Structural and genomic features of clostridial neurotoxins. In: Alouf JE J Freer, editors. The Comprehensive Sourcebook of Bacterial Protein Toxins. London, UK: Academic Press; 1999. pp. 174–201.
   Google Scholar
• Doxey AC, Lynch MDJ, Müller KM, et al. Insights into the evolutionary origins of clostridial neurotoxins from analysis of the Clostridium botulinum strain a neurotoxin gene cluster. BMC Evol Biol. 2008;8(1):14.
   PubMedGoogle Scholar
• Popoff MR, Bouvet P. Genetic characteristics of toxigenic Clostridia and toxin gene evolution. Toxicon. 2013;75:63–89.
   PubMed Web of Science ®Google Scholar
• Nowakowska MB, Douillard FP, Lindström M. Looking for the X Factor in Bacterial Pathogenesis: association of orfX-p47 Gene Clusters with Toxin Genes in Clostridial and Non-Clostridial Bacterial Species. Toxins (Basel). 2019;12(1):19.
   PubMed Web of Science ®Google Scholar
• Dupuy B, Matamouros S. Regulation of toxin and bacteriocin synthesis in Clostridium species by a new subgroup of RNA polymerase σ-factors. Res Microbiol. 2006;157(3):201–205.
   PubMed Web of Science ®Google Scholar
• Marvaud JC, Gibert M, Inoue K, et al. botR/A is a positive regulator of botulinum neurotoxin and associated non-toxin protein genes in Clostridium botulinum a. Mol Microbiol. 1998;29(4):1009–1018.
   PubMed Web of Science ®Google Scholar
• Raffestin S, Marvaud JC, Cerrato R, et al. Organization and regulation of the neurotoxin genes in Clostridium botulinum and Clostridium tetani. Anaerobe. 2004;10(2):93–100.
   PubMed Web of Science ®Google Scholar
• Raffestin S, Dupuy B, Marvaud JC, et al. BotR/A and TetR are alternative RNA polymerase sigma factors controlling the expression of the neurotoxin and associated protein genes in Clostridium botulinum type a and Clostridium tetani. Mol Microbiol. 2004;55(1):235–249.
   Web of Science ®Google Scholar
• Dover N, Barash JR, Hill KK, et al. Novel Structural Elements within the Nonproteolytic Clostridium botulinum Type F Toxin Gene Cluster. Appl Environ Microbiol. 2011;77(5):1904.
   PubMed Web of Science ®Google Scholar
• Collins MD, East AK. Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins. J Appl Microbiol. 1998;84:5–17.
   PubMed Web of Science ®Google Scholar
• Smith TJ, Williamson CHD, Hill KK, et al. The Distinctive Evolution of orfX Clostridium parabotulinum Strains and Their Botulinum Neurotoxin Type a and F Gene Clusters is Influenced by Environmental Factors and Gene Interactions via Mobile Genetic Elements. Front Microbiol. 2021;12:566908.
   PubMed Web of Science ®Google Scholar
• Mansfield MJ, Adams JB, Doxey AC. Botulinum neurotoxin homologs in non-Clostridium species. FEBS Lett. 2015;589:342–348.
   PubMed Web of Science ®Google Scholar
• Dover N, Barash JR, Burke JN, et al. Arrangement of the Clostridium baratii F7 Toxin Gene Cluster with Identification of a σ Factor That Recognizes the Botulinum Toxin Gene Cluster Promoters. PLoS ONE. 2014;9:e97983.
   PubMed Web of Science ®Google Scholar
• Oguma K. The stability of toxigenicity in Clostridium botulinum types C and D. J Gen Microbiol. 1976;92(1):67–75.
   PubMedGoogle Scholar
• Hariharan H, Mitchell WR. Observations on bacteriophages of Clostridium botulinum type C isolates from different sources and the role of certain phages in toxigenicity. Appl Environ Microbiol. 1976;32:145–158.
   PubMed Web of Science ®Google Scholar
• Smith TJ, Hill KK, Foley BT, et al. Analysis of the Neurotoxin Complex Genes in Clostridium botulinum A1-A4 and B1 Strains: BoNT/A3, /Ba4 and /B1 Clusters Are Located within Plasmids. PLoS ONE. 2007;2(12):e1271.
   Google Scholar
• Marshall KM, Bradshaw M, Pellett S, et al. Plasmid Encoded Neurotoxin Genes in Clostridium botulinum Serotype a Subtypes. Biochem Biophys Res Commun. 2007;361:49.
   PubMed Web of Science ®Google Scholar
• Franciosa G, Maugliani A, Scalfaro C, et al. Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains. PLoS ONE. 2009;4(3):4.
   Web of Science ®Google Scholar
• Zhang Z, Hintsa H, Chen Y, et al. Plasmid-Borne Type E Neurotoxin Gene Clusters in Clostridium botulinum Strains. Appl Environ Microbiol. 2013;79:3856.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Sugiyama H, Nakano H, et al. The genes for the Clostridium botulinum type G toxin complex are on a plasmid. Infect Immun. 1995;63(5):2087.
   PubMed Web of Science ®Google Scholar
• Raphael BH, Bradshaw M, Kalb SR, et al. Clostridium botulinum Strains Producing BoNT/F4 or BoNT/F5. Appl Environ Microbiol. 2014;80:3250.
   PubMed Web of Science ®Google Scholar
• Dover N, Barash JR, Hill KK, et al. Clostridium botulinum Strain Af84 Contains Three Neurotoxin Gene Clusters: bont/A2, bont/F4 and bont/F5. PLoS ONE. 2013;8(4):e61205.
   PubMed Web of Science ®Google Scholar
• Marshall KM, Bradshaw M, Johnson EA. Conjugative Botulinum Neurotoxin-Encoding Plasmids in Clostridium botulinum. PLoS ONE. 2010;5(6):e11087.
   PubMed Web of Science ®Google Scholar
• Nawrocki EM, Bradshaw M, Johnson EA. Botulinum neurotoxin–encoding plasmids can be conjugatively transferred to diverse Clostridial strains. Sci Rep. 2018;8(1).
   Google Scholar
• Smith TJ, Tian R, Imanian B, et al. Integration of Complete Plasmids Containing Bont Genes into Chromosomes of Clostridium parabotulinum, Clostridium sporogenes, and Clostridium argentinense. Toxins (Basel). 2021;13(7):473.
   PubMed Web of Science ®Google Scholar
• Dineen SS, Bradshaw M, Johnson EA. Neurotoxin gene clusters in Clostridium botulinum type a strains: sequence comparison and evolutionary implications. Curr Microbiol. 2003;46(5):345–352.
   PubMed Web of Science ®Google Scholar
• Hill KK, Xie G, Foley BT, et al. Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains. BMC Biol. 2009;7(1):66.
   PubMedGoogle Scholar
• Frankel G, Newton SMC, Schoolnik GK, et al. Intragenic recombination in a flagellin gene: characterization of the H1-j gene of Salmonella typhi. EMBO J. 1989;8(10):3149.
   PubMed Web of Science ®Google Scholar
• Harrington CS, Thomson-Carter FM, Carter PE. Evidence for recombination in the flagellin locus of Campylobacter jejuni: implications for the flagellin gene typing scheme. J Clin Microbiol. 1997;35(9):2386–2392.
   PubMed Web of Science ®Google Scholar
• Carter AT, Paul CJ, Mason DR, et al. Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum. BMC Genomics. 2009;10(1):115.
   PubMedGoogle Scholar
• Bradshaw M, Dineen SS, Maks ND, et al. Regulation of neurotoxin complex expression in Clostridium botulinum strains 62A, Hall A-hyper, and NCTC 2916. Anaerobe. 2004;10(6):321–333.
   PubMed Web of Science ®Google Scholar
• Bonventre PF, Kempe LL. Physiology of toxin production by Clostridium botulinum types a and B. I. Growth, autolysis, and toxin production. J Bacteriol. 1960;79:18–23.
   PubMed Web of Science ®Google Scholar
• Couesnon A, Raffestin S, Popoff MR. Expression of botulinum neurotoxins a and E, and associated non-toxin genes, during the transition phase and stability at high temperature: analysis by quantitative reverse transcription-PCR. Microbiology. 2006;152(3):759–770.
   PubMedGoogle Scholar
• Ihekwaba AEC, Mura I, Malakar PK, et al. New elements to consider when modeling the hazards associated with botulinum neurotoxin in food. J Bacteriol. 2016;198(2):204–211.
   PubMed Web of Science ®Google Scholar
• Connan C, Denève C, Mazuet C, et al. Regulation of toxin synthesis in Clostridium botulinum and Clostridium tetani. Toxicon. 2013;75:90–100.
   PubMed Web of Science ®Google Scholar
• Cooksley CM, Davis IJ, Winzer K, et al. Regulation of neurotoxin production and sporulation by a putative agrBD signaling system in proteolytic Clostridium botulinum. Appl Environ Microbiol. 2010;76(13):4448–4460.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Korkeala H, Dahlsten E, et al. Two-Component Signal Transduction System CBO0787/CBO0786 Represses Transcription from Botulinum Neurotoxin Promoters in Clostridium botulinum ATCC 3502. PLOS Pathogens. 2013;9(3):e1003252.
   PubMed Web of Science ®Google Scholar
• Connan C, Popoff MR. Two-component systems and toxinogenesis regulation in Clostridium botulinum. Res Microbiol. 2015;166(4):332–343.
   PubMed Web of Science ®Google Scholar
• Bonventre PF, Kempe LL. Physiology of toxin production by Clostridium botulinum types a and B. III. Effect of pH and temperature during incubation on growth, autolysis. and toxin production. Appl Microbiol. 1959;7(6):374–377.
   PubMedGoogle Scholar
• Leyer GJ, Johnson EA. Repression of toxin production by tryptophan in Clostridium botulinum type E. Arch Microbiol. 1990;154(5):443–447.
   PubMed Web of Science ®Google Scholar
• Fredrick CM, Lin G, Johnson EA. Regulation of botulinum neurotoxin synthesis and toxin complex formation by arginine and glucose in Clostridium botulinum ATCC 3502. Appl Environ Microbiol. 2017;83(13).
   PubMed Web of Science ®Google Scholar
• Bowers LE, Williams OB. Effect of arginine on growth and lysis of Clostridium botulinum. J Bacteriol. 1963;85:1175.
   PubMed Web of Science ®Google Scholar
• Inzalaco HN, Tepp WH, Fredrick C, et al. Posttranslational Regulation of Botulinum Neurotoxin Production in Clostridium botulinum Hall A- hyper. mSphere. 2021;6(4):6.
   Web of Science ®Google Scholar
• Zhang Z, Dahlsten E, Korkeala H, et al. Positive regulation of botulinum neurotoxin gene expression by CodY in Clostridium botulinum ATCC 3502. Appl Environ Microbiol. 2014;80:7651–7658.
   PubMed Web of Science ®Google Scholar
• Ihekwaba AEC, Mura I, Walshaw J, et al. An Integrative Approach to Computational Modelling of the Gene Regulatory Network Controlling Clostridium botulinum Type A1 Toxin Production. PLoS Comput Biol. 2016;12(11):e1005205.
   PubMed Web of Science ®Google Scholar
• Piggot PJ, Hilbert DW. Sporulation of Bacillus subtilis. Curr Opin Microbiol. 2004;7:579–586.
   PubMed Web of Science ®Google Scholar
• Paredes CJ, Alsaker KV, Papoutsakis ET. A comparative genomic view of clostridial sporulation and physiology. Nature Rev Microbiol. 2005;3(12):969–978.
   PubMed Web of Science ®Google Scholar
• Tan IS, Ramamurthi KS. Spore formation in Bacillus subtilis. Environ Microbiol Rep. 2014;6:212–225.
   PubMed Web of Science ®Google Scholar
• Wörner K, Szurmant H, Chiang C, et al. Phosphorylation and functional analysis of the sporulation initiation factor Spo0A from Clostridium botulinum. Mol Microbiol. 2006;59:1000–1012.
   PubMed Web of Science ®Google Scholar
• Davidson P, Eutsey R, Redler B, et al. Flexibility and constraint: evolutionary remodeling of the sporulation initiation pathway in Firmicutes. PLoS Genet. 2018;14(9):e1007470.
   PubMed Web of Science ®Google Scholar
• Hoch JA. Regulation of the phosphorelay and the initiation of sporulation in Bacillus subtilis. Annu Rev Microbiol. 1993;47(1):441–465.
   PubMedGoogle Scholar
• Kirk DG, Zhang Z, Korkeala H, et al. Alternative sigma factors SigF, SigE, and SigG are essential for sporulation in Clostridium botulinum ATCC 3502. Appl Environ Microbiol. 2014;80:5141–5150.
   PubMed Web of Science ®Google Scholar
• Kirk DG, Palonen E, Korkeala H, et al. Evaluation of normalization reference genes for RT-Qpcr analysis of spo0A and four sporulation sigma factor genes in Clostridium botulinum Group I strain ATCC 3502. Anaerobe. 2014;26:14–19.
   PubMed Web of Science ®Google Scholar
• Mascher G, Mertaoja A, Korkeala H, et al. Neurotoxin synthesis is positively regulated by the sporulation transcription factor Spo0A in Clostridium botulinum type E. Environ Microbiol. 2017;19(10):4287–4300.
   PubMed Web of Science ®Google Scholar
• Imae Y, Strominger JL. Cortex content of asporogenous mutants of Bacillus subtilis. J Bacteriol. 1976;126(2):914–918.
   PubMed Web of Science ®Google Scholar
• Setlow P. Spores of Bacillus subtilis: their resistance to and killing by radiation, heat and chemicals. J Appl Microbiol. 2006;101(3):514–525.
   PubMed Web of Science ®Google Scholar
• Portinha IM, Douillard FP, Korkeala H, et al. Sporulation Strategies and Potential Role of the Exosporium in Survival and Persistence of Clostridium botulinum. Int J Mol Sci. 2022;23(2):23.
   Web of Science ®Google Scholar
• Setlow P. Germination of spores of Bacillus species: what we know and do not know. J Bacteriol. 2014;196:1297–1305.
   PubMed Web of Science ®Google Scholar
• Moir A. How do spores germinate? J Appl Microbiol. 2006;101:526–530.
   PubMed Web of Science ®Google Scholar
• Brunt J, van Vliet AHM, van den Bos F, et al. Diversity of the germination apparatus in Clostridium botulinum groups I, II, III, and IV. Front Microbiol. 2016;7:1702. DOI:10.3389/fmicb.2016.01702.
   PubMed Web of Science ®Google Scholar
• Clauwers C, Lood C, Van Noort V, et al. Canonical germinant receptor is dispensable for spore germination in Clostridium botulinum group II strain NCTC 11219. Sci Rep. 2017;7:1–10.
   PubMed Web of Science ®Google Scholar
• Ross C, Abel-Santos E. The Ger Receptor Family from Sporulating Bacteria. Curr Issues Mol Biol. 2010;12:147.
   PubMed Web of Science ®Google Scholar
• Brunt J, Carter AT, Pye HV, et al. The orphan germinant receptor protein GerXAO (but not GerX3b) is essential for L-alanine induced germination in Clostridium botulinum Group II. Sci Rep. 2018;8(1):1–10.
   PubMedGoogle Scholar
• Cañadas IC, Groothuis D, Zygouropoulou M, et al. RiboCas: a Universal CRISPR-Based Editing Tool for Clostridium. ACS Synth Biol. 2019;8(6):1379–1390.
   PubMed Web of Science ®Google Scholar
• Mertaoja A, Nowakowska MB, Mascher G, et al. CRISPR-Cas9-Based Toolkit for Clostridium botulinum Group II Spore and Sporulation Research. Front Microbiol. 2021;12:32.
   Web of Science ®Google Scholar
• Heap JT, Pennington OJ, Cartman ST, et al. The ClosTron: a universal gene knock-out system for the genus Clostridium. J Microbiol Methods. 2007;70:452–464.
   PubMed Web of Science ®Google Scholar
• Heap JT, Ehsaan M, Cooksley CM, et al. Integration of DNA into bacterial chromosomes from plasmids without a counter-selection marker. Nucleic Acids Res. 2012;40(8):e59.
   PubMed Web of Science ®Google Scholar
• Nowakowska MB, Selby K, Przykopanski A, et al. Construction and validation of safe Clostridium botulinum Group II surrogate strain producing inactive botulinum neurotoxin type E toxoid. Sci Rep. 2022;12(1):1790.
   PubMed Web of Science ®Google Scholar
• Chen S, Barbieri JT. Engineering botulinum neurotoxin to extend therapeutic intervention. Proc Natl Acad Sci, USA. 2009;106:9180–9184.
   PubMed Web of Science ®Google Scholar
• Vazquez-Cintron EJ, Vakulenko M, Band PA, et al. Atoxic derivative of botulinum neurotoxin a as a prototype molecular vehicle for targeted delivery to the neuronal cytoplasm. PLoS ONE. 2014;9(1):e85517.
   PubMed Web of Science ®Google Scholar
• Vazquez-Cintron E, Tenezaca L, Angeles C, et al. Pre-clinical study of a novel recombinant botulinum neurotoxin derivative engineered for improved safety. Sci Rep. 2016;6:6.
   PubMed Web of Science ®Google Scholar
• Tao L, Peng L, Berntsson RP-A, et al. Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors. Nat Commun. 2017; 8(1).
   Google Scholar
• Guo J, Pan X, Zhao Y, et al. Engineering clostridia neurotoxins with elevated catalytic activity. Toxicon. 2013;74:158–166.
   PubMed Web of Science ®Google Scholar